AI² Robotics, a Shenzhen-based developer of general-purpose robots, has announced the completion of a Series B financing round worth more than RMB1 billion, marking one of the larger recent funding events in China’s embodied AI sector. Media coverage says the transaction pushes the company’s valuation above $1.45 billion and extends a fast pace of capital raising, with the startup reporting 12 financing rounds over the past year, including five tranches within the broader Series B. Founded in April 2023 by Dr. Yandong Guo, the company is focused on production-oriented robots designed for real-world work in factories, commercial environments, and public-service settings rather than purely showcase applications.
Funding and Investor Backing
According to the company and subsequent reports, the investor group spans internet and AI companies, state-backed industrial capital, private equity, brokerage-linked funds, and strategic partners tied to manufacturing and the Tesla supply chain. Named participants in public coverage include Baidu, CRRC Capital, Yusys Technologies, Sailun Group, Yunbai Capital, and funds associated with Guotai Haitong, a mix that suggests investors are backing both the technical roadmap and the company’s potential to commercialize at scale. AI² Robotics said the new capital will primarily support continued development of its embodied AI stack, product upgrades for the AlphaBot family, manufacturing expansion, and deeper deployment in priority industry use cases.
Technology and Product Roadmap
The company has consistently framed its strategy around end-to-end vision-language-action development, with its proprietary Alpha Brain system and GOVLA model serving as the software core for its robots. On its official website, AI² Robotics says it released an open-source GOVLA model in June 2025 and claims it outperformed the π0 benchmark by 30% in third-party evaluations, while public reports this week described the company as an early mover in China’s VLA field. Gasgoo also reported that the latest AlphaBot 2 uses a wheeled, dual-arm architecture and that key components have surpassed 50,000 hours of failure-free operation, a specification the company presents as meeting industrial-grade reliability requirements.
Commercial Rollout and Manufacturing Scale
Commercial traction is now central to the story, with AI² Robotics saying AlphaBot systems have already been deployed across automotive, biotechnology, semiconductor display, and public-service settings, where they perform tasks such as sorting, transport, and labeling. The company’s LinkedIn page also highlights the recent launch of its modular “AlphaBot Cube” service format in Beijing and Shenzhen, signaling a broader push beyond factory automation into retail, hospitality, and urban consumer-facing environments. On the manufacturing side, the company said it brought its own production line online in September 2025, reached triple-digit monthly deliveries by December, has current annual capacity of about 1,000 units, and plans to scale that figure to 10,000 units during 2026.
Taken together, the financing round positions AI² Robotics as one of the better-funded private players in China’s embodied AI market, where investors are increasingly favoring companies that can pair model innovation with dependable hardware and repeatable deployment. The scale of the raise matters, but the more important test will be execution: converting fresh capital into higher-volume production, stable field performance, and paying customer demand across industrial and service environments. If the company can translate its technical claims and recent pilot deployments into sustained commercial delivery, this funding milestone could mark a significant step in its transition from fast-rising startup to serious robotics manufacturer.